| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Neuropathies | 14 | 2024 | 41 | 2.260 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2022 | 192 | 1.370 |
Why?
|
| Insulin-Secreting Cells | 8 | 2022 | 430 | 0.990 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2024 | 1 | 0.880 |
Why?
|
| Hypotension, Orthostatic | 1 | 2024 | 4 | 0.880 |
Why?
|
| Neural Conduction | 7 | 2024 | 71 | 0.820 |
Why?
|
| Autoimmunity | 1 | 2024 | 177 | 0.780 |
Why?
|
| Hyperglycemia | 3 | 2015 | 176 | 0.730 |
Why?
|
| Ganglia, Spinal | 6 | 2024 | 76 | 0.650 |
Why?
|
| Vital Statistics | 1 | 2018 | 3 | 0.610 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 760 | 0.590 |
Why?
|
| Insulin | 10 | 2022 | 1168 | 0.580 |
Why?
|
| Gastric Inhibitory Polypeptide | 4 | 2018 | 10 | 0.480 |
Why?
|
| Islets of Langerhans | 4 | 2022 | 555 | 0.470 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2011 | 56 | 0.450 |
Why?
|
| Glucagon | 3 | 2022 | 113 | 0.400 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2015 | 408 | 0.390 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 374 | 0.380 |
Why?
|
| Mice | 28 | 2024 | 12133 | 0.370 |
Why?
|
| Liver Neoplasms | 4 | 2015 | 764 | 0.360 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 69 | 0.350 |
Why?
|
| Animals | 39 | 2024 | 28059 | 0.350 |
Why?
|
| Neuronal Outgrowth | 4 | 2024 | 6 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 3376 | 0.340 |
Why?
|
| Hepatocytes | 1 | 2011 | 127 | 0.340 |
Why?
|
| Point-of-Care Systems | 2 | 2024 | 147 | 0.340 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 177 | 0.330 |
Why?
|
| Liver | 10 | 2017 | 1225 | 0.330 |
Why?
|
| Quality Control | 1 | 2010 | 117 | 0.320 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 91 | 0.320 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 323 | 0.310 |
Why?
|
| Weight Gain | 3 | 2018 | 124 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2020 | 574 | 0.300 |
Why?
|
| Calmodulin | 2 | 2007 | 50 | 0.300 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 2 | 2024 | 3 | 0.290 |
Why?
|
| Rats | 13 | 2022 | 4073 | 0.280 |
Why?
|
| Proglucagon | 3 | 2022 | 5 | 0.270 |
Why?
|
| Autoantibodies | 3 | 2024 | 278 | 0.270 |
Why?
|
| Stem Cells | 2 | 2020 | 382 | 0.270 |
Why?
|
| Fibroblast Growth Factors | 3 | 2017 | 83 | 0.270 |
Why?
|
| Venoms | 1 | 2007 | 12 | 0.270 |
Why?
|
| Peptides | 3 | 2022 | 655 | 0.250 |
Why?
|
| Neurons | 5 | 2024 | 1599 | 0.250 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 2010 | 0.250 |
Why?
|
| Hypoglycemic Agents | 2 | 2019 | 361 | 0.250 |
Why?
|
| Diet, High-Fat | 2 | 2018 | 128 | 0.240 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 2 | 2017 | 4 | 0.240 |
Why?
|
| Peripheral Nerves | 2 | 2022 | 39 | 0.240 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 259 | 0.240 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 61 | 0.230 |
Why?
|
| Neuropeptides | 1 | 2005 | 114 | 0.230 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2024 | 10 | 0.220 |
Why?
|
| Neurotransmitter Agents | 1 | 2005 | 108 | 0.220 |
Why?
|
| Electroretinography | 2 | 2020 | 79 | 0.210 |
Why?
|
| Catecholamines | 1 | 2024 | 92 | 0.210 |
Why?
|
| Insulin Resistance | 5 | 2019 | 375 | 0.210 |
Why?
|
| Diabetic Retinopathy | 2 | 2020 | 92 | 0.200 |
Why?
|
| Serotonin | 1 | 2024 | 219 | 0.200 |
Why?
|
| Histological Techniques | 1 | 2022 | 36 | 0.200 |
Why?
|
| Dopamine | 1 | 2024 | 274 | 0.190 |
Why?
|
| Culture Media, Conditioned | 2 | 2020 | 103 | 0.190 |
Why?
|
| Cell Line | 7 | 2021 | 2504 | 0.190 |
Why?
|
| Apoptosis | 5 | 2021 | 1737 | 0.190 |
Why?
|
| Diet, High-Protein | 1 | 2022 | 1 | 0.190 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2022 | 26 | 0.190 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 32 | 0.190 |
Why?
|
| Dietary Carbohydrates | 2 | 2018 | 39 | 0.180 |
Why?
|
| Nerve Fibers | 2 | 2019 | 49 | 0.180 |
Why?
|
| Japan | 2 | 2019 | 306 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 974 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2024 | 1211 | 0.180 |
Why?
|
| Electrocardiography | 1 | 2024 | 507 | 0.180 |
Why?
|
| Peripheral Nervous System | 1 | 2021 | 21 | 0.180 |
Why?
|
| Pyruvaldehyde | 1 | 2021 | 11 | 0.180 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2019 | 39 | 0.170 |
Why?
|
| Tooth, Deciduous | 1 | 2020 | 3 | 0.170 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 30 | 0.170 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 21 | 0.170 |
Why?
|
| Glucagon-Like Peptides | 1 | 2020 | 12 | 0.170 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 69 | 0.170 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2018 | 122 | 0.160 |
Why?
|
| Thermosensing | 1 | 2019 | 4 | 0.160 |
Why?
|
| Arginase | 4 | 2001 | 16 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2022 | 464 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 149 | 0.160 |
Why?
|
| Spiro Compounds | 1 | 2019 | 26 | 0.160 |
Why?
|
| Male | 23 | 2024 | 43929 | 0.160 |
Why?
|
| Dental Pulp | 1 | 2019 | 4 | 0.160 |
Why?
|
| Calcium Channels, L-Type | 1 | 2019 | 38 | 0.160 |
Why?
|
| Rats, Wistar | 4 | 2019 | 305 | 0.160 |
Why?
|
| Electrodiagnosis | 1 | 2019 | 8 | 0.150 |
Why?
|
| Pyrazines | 1 | 2019 | 92 | 0.150 |
Why?
|
| Mice, Knockout | 6 | 2020 | 2098 | 0.150 |
Why?
|
| Exocytosis | 1 | 2019 | 110 | 0.150 |
Why?
|
| Retina | 1 | 2020 | 225 | 0.150 |
Why?
|
| Cyclin D2 | 1 | 2018 | 20 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2015 | 15 | 0.140 |
Why?
|
| Cells, Cultured | 7 | 2024 | 2903 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2019 | 612 | 0.140 |
Why?
|
| Glucose | 3 | 2018 | 683 | 0.140 |
Why?
|
| Humans | 27 | 2024 | 92352 | 0.140 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 190 | 0.140 |
Why?
|
| Organ Specificity | 3 | 2017 | 282 | 0.140 |
Why?
|
| Diet, Carbohydrate Loading | 1 | 2017 | 2 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2020 | 261 | 0.140 |
Why?
|
| Cause of Death | 1 | 2018 | 270 | 0.140 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 13 | 0.140 |
Why?
|
| Middle Aged | 12 | 2024 | 27045 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 319 | 0.140 |
Why?
|
| Dietary Fats | 1 | 2018 | 136 | 0.130 |
Why?
|
| Mice, Transgenic | 7 | 2007 | 1593 | 0.130 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2017 | 29 | 0.130 |
Why?
|
| Myoblasts | 1 | 2017 | 32 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 94 | 0.130 |
Why?
|
| Energy Metabolism | 3 | 2017 | 302 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 51 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 651 | 0.130 |
Why?
|
| Neurites | 3 | 2024 | 36 | 0.120 |
Why?
|
| Autoantigens | 3 | 2002 | 137 | 0.120 |
Why?
|
| Glycolysis | 1 | 2017 | 184 | 0.120 |
Why?
|
| Glucose Tolerance Test | 4 | 2019 | 232 | 0.120 |
Why?
|
| Clostridium | 1 | 2015 | 24 | 0.120 |
Why?
|
| Palmitic Acid | 1 | 2015 | 29 | 0.110 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Tissue Culture Techniques | 2 | 2011 | 81 | 0.110 |
Why?
|
| Liver Diseases | 4 | 2001 | 245 | 0.110 |
Why?
|
| Drug Hypersensitivity Syndrome | 1 | 2014 | 3 | 0.110 |
Why?
|
| KATP Channels | 1 | 2014 | 20 | 0.110 |
Why?
|
| Diabetic Foot | 1 | 2014 | 15 | 0.110 |
Why?
|
| Roseolovirus Infections | 1 | 2014 | 9 | 0.110 |
Why?
|
| Herpesvirus 6, Human | 1 | 2014 | 21 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2015 | 101 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 402 | 0.110 |
Why?
|
| Female | 14 | 2024 | 47901 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2020 | 2037 | 0.110 |
Why?
|
| Adipocytes, White | 1 | 2013 | 6 | 0.110 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2013 | 5 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 64 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1247 | 0.100 |
Why?
|
| Keratinocytes | 1 | 2014 | 147 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 192 | 0.100 |
Why?
|
| Steroids | 1 | 2014 | 173 | 0.100 |
Why?
|
| Blood Glucose | 3 | 2019 | 855 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 670 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 142 | 0.100 |
Why?
|
| Wound Healing | 2 | 2014 | 371 | 0.100 |
Why?
|
| Cell Communication | 1 | 2013 | 205 | 0.100 |
Why?
|
| Neural Crest | 1 | 2012 | 33 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2012 | 465 | 0.090 |
Why?
|
| Diet | 1 | 2015 | 448 | 0.090 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2011 | 21 | 0.090 |
Why?
|
| Calcineurin | 1 | 2011 | 19 | 0.090 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2011 | 28 | 0.090 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 50 | 0.090 |
Why?
|
| Response Elements | 1 | 2011 | 66 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1607 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 705 | 0.090 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2022 | 56 | 0.090 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2020 | 39 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 131 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2011 | 140 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2730 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1172 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2015 | 679 | 0.080 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2010 | 38 | 0.080 |
Why?
|
| Macrophages | 1 | 2013 | 601 | 0.080 |
Why?
|
| Protein Transport | 1 | 2011 | 430 | 0.080 |
Why?
|
| Cytodiagnosis | 3 | 1985 | 45 | 0.080 |
Why?
|
| Cell Survival | 3 | 2021 | 1006 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2002 | 461 | 0.080 |
Why?
|
| Biomarkers | 4 | 2013 | 1847 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2022 | 3505 | 0.070 |
Why?
|
| Creatine Kinase | 2 | 1998 | 53 | 0.070 |
Why?
|
| Receptors, Glucagon | 2 | 2020 | 11 | 0.070 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 15 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 124 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 184 | 0.060 |
Why?
|
| United States | 1 | 2018 | 7367 | 0.060 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2018 | 7 | 0.060 |
Why?
|
| Aged | 6 | 2024 | 19953 | 0.060 |
Why?
|
| Streptozocin | 2 | 2016 | 55 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2019 | 280 | 0.060 |
Why?
|
| Mice, Inbred ICR | 1 | 2005 | 74 | 0.060 |
Why?
|
| Benzoates | 1 | 2005 | 33 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 740 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 887 | 0.060 |
Why?
|
| Tetrazoles | 1 | 2005 | 24 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2007 | 245 | 0.060 |
Why?
|
| Diabetic Angiopathies | 1 | 2005 | 36 | 0.060 |
Why?
|
| Valine | 1 | 2005 | 60 | 0.060 |
Why?
|
| Adult | 5 | 2020 | 27547 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 46 | 0.060 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 99 | 0.060 |
Why?
|
| Linagliptin | 1 | 2024 | 1 | 0.060 |
Why?
|
| Sitagliptin Phosphate | 1 | 2024 | 2 | 0.060 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2024 | 5 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1920 | 0.060 |
Why?
|
| Neuropeptide Y | 1 | 2024 | 32 | 0.060 |
Why?
|
| Chemokine CXCL12 | 1 | 2024 | 39 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2005 | 109 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2793 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2024 | 190 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 1016 | 0.050 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2022 | 2 | 0.050 |
Why?
|
| Clonal Deletion | 1 | 2002 | 23 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 68 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2022 | 136 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2022 | 32 | 0.050 |
Why?
|
| Pancreatic Hormones | 1 | 2022 | 15 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2022 | 154 | 0.050 |
Why?
|
| Liver Transplantation | 2 | 2001 | 1186 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2022 | 103 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 68 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 475 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 2450 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2002 | 201 | 0.040 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2020 | 3 | 0.040 |
Why?
|
| Retinal Photoreceptor Cell Inner Segment | 1 | 2020 | 4 | 0.040 |
Why?
|
| Cell Death | 1 | 2022 | 260 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2020 | 10 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2020 | 13 | 0.040 |
Why?
|
| Tooth Exfoliation | 1 | 2020 | 2 | 0.040 |
Why?
|
| Fovea Centralis | 1 | 2020 | 21 | 0.040 |
Why?
|
| Ankle Brachial Index | 1 | 2020 | 28 | 0.040 |
Why?
|
| Gene Expression | 1 | 2005 | 1312 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2021 | 109 | 0.040 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2020 | 31 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2020 | 22 | 0.040 |
Why?
|
| Cell Separation | 1 | 2020 | 203 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 73 | 0.040 |
Why?
|
| Autophagy | 1 | 2022 | 170 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 2019 | 9 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 191 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2001 | 268 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6918 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2020 | 134 | 0.040 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 1999 | 2 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2002 | 419 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2019 | 38 | 0.040 |
Why?
|
| Epidermis | 1 | 2019 | 102 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1761 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2002 | 360 | 0.040 |
Why?
|
| Calcitonin | 1 | 2019 | 39 | 0.040 |
Why?
|
| Cell Movement | 2 | 2020 | 801 | 0.040 |
Why?
|
| Hypertension | 1 | 2005 | 763 | 0.040 |
Why?
|
| Phosphocreatine | 1 | 1998 | 14 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 206 | 0.040 |
Why?
|
| Substance P | 1 | 2019 | 62 | 0.040 |
Why?
|
| Motor Skills | 1 | 2019 | 79 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 785 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 397 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2017 | 1688 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 786 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 155 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 95 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 146 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2020 | 708 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 999 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 503 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2002 | 478 | 0.040 |
Why?
|
| Starch | 1 | 2017 | 8 | 0.030 |
Why?
|
| Antioxidants | 1 | 2019 | 224 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 19 | 0.030 |
Why?
|
| Uncoupling Protein 1 | 1 | 2017 | 43 | 0.030 |
Why?
|
| Graft Survival | 1 | 2001 | 935 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 27 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 58 | 0.030 |
Why?
|
| Hexokinase | 1 | 2017 | 22 | 0.030 |
Why?
|
| Oxyhemoglobins | 1 | 1996 | 30 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2017 | 87 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2020 | 578 | 0.030 |
Why?
|
| Mitochondria | 1 | 2021 | 595 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 53 | 0.030 |
Why?
|
| Endotoxins | 1 | 1996 | 38 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 284 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 76 | 0.030 |
Why?
|
| Erythrocytes | 2 | 2001 | 251 | 0.030 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2015 | 20 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3776 | 0.030 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2015 | 12 | 0.030 |
Why?
|
| Ectoderm | 1 | 2015 | 31 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2001 | 1110 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2015 | 50 | 0.030 |
Why?
|
| Hepatectomy | 1 | 1996 | 174 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2002 | 1105 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2015 | 38 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1900 | 0.030 |
Why?
|
| Phlorhizin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diazoxide | 1 | 2014 | 19 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1994 | 5 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2015 | 129 | 0.030 |
Why?
|
| Lung Diseases | 1 | 1996 | 283 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 58 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 80 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 127 | 0.030 |
Why?
|
| Foot | 1 | 2014 | 56 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 2014 | 67 | 0.030 |
Why?
|
| Prognosis | 2 | 2019 | 3872 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2013 | 19 | 0.030 |
Why?
|
| Adipokines | 1 | 2013 | 18 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 35 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 32 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 50 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 155 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2013 | 62 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 171 | 0.030 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2012 | 6 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 29 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2012 | 17 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 32 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 179 | 0.020 |
Why?
|
| Incretins | 1 | 2012 | 14 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1720 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 127 | 0.020 |
Why?
|
| Mass Screening | 2 | 1989 | 675 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 158 | 0.020 |
Why?
|
| Ovalbumin | 2 | 2002 | 109 | 0.020 |
Why?
|
| Child | 2 | 2020 | 7309 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 559 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1232 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 354 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2011 | 53 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 121 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2012 | 311 | 0.020 |
Why?
|
| Intestines | 1 | 1994 | 426 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1241 | 0.020 |
Why?
|
| Immunization, Secondary | 2 | 2002 | 35 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 595 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 707 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 407 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1991 | 119 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 452 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1804 | 0.020 |
Why?
|
| Quality of Life | 1 | 1996 | 1745 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 701 | 0.020 |
Why?
|
| Reference Values | 2 | 2001 | 660 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 1014 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1989 | 306 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 2 | 1985 | 222 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 1996 | 251 | 0.020 |
Why?
|
| Valsartan | 1 | 2005 | 11 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 2005 | 61 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 95 | 0.010 |
Why?
|
| Probability | 1 | 1985 | 358 | 0.010 |
Why?
|
| Colonic Neoplasms | 2 | 2001 | 581 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1989 | 1270 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 1090 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2002 | 20 | 0.010 |
Why?
|
| Clonal Anergy | 1 | 2002 | 32 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 128 | 0.010 |
Why?
|
| Convalescence | 1 | 2001 | 12 | 0.010 |
Why?
|
| Hepatitis | 1 | 2001 | 35 | 0.010 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2001 | 3 | 0.010 |
Why?
|
| Calibration | 1 | 2001 | 103 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 8730 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 907 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 2001 | 77 | 0.010 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2001 | 66 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2002 | 219 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 283 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 793 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2001 | 146 | 0.010 |
Why?
|
| Acute Disease | 1 | 2001 | 855 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2001 | 460 | 0.010 |
Why?
|
| Self Tolerance | 1 | 1999 | 26 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 172 | 0.010 |
Why?
|
| Galactosamine | 1 | 1998 | 8 | 0.010 |
Why?
|
| Neoplasms | 3 | 1985 | 3123 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1999 | 173 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1998 | 72 | 0.010 |
Why?
|
| Transgenes | 1 | 1999 | 183 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1998 | 75 | 0.010 |
Why?
|
| Lupus Nephritis | 1 | 1999 | 78 | 0.010 |
Why?
|
| Necrosis | 1 | 1998 | 209 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 645 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1998 | 276 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 301 | 0.010 |
Why?
|
| Sulfur Dioxide | 1 | 1996 | 1 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 2009 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1996 | 29 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1996 | 26 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1996 | 58 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1996 | 64 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1996 | 63 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1996 | 63 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1996 | 70 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 109 | 0.010 |
Why?
|
| Portal Vein | 1 | 1996 | 121 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 449 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 1398 | 0.010 |
Why?
|
| Sepsis | 1 | 1998 | 353 | 0.010 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 1994 | 7 | 0.010 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 1994 | 10 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 258 | 0.010 |
Why?
|
| Kinetics | 1 | 1996 | 1552 | 0.010 |
Why?
|
| Gallbladder Neoplasms | 1 | 1993 | 23 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 324 | 0.010 |
Why?
|
| Hemolysis | 1 | 1993 | 62 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 1279 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 1045 | 0.010 |
Why?
|
| Cytokines | 1 | 1996 | 842 | 0.010 |
Why?
|
| Survival Rate | 1 | 1996 | 1926 | 0.010 |
Why?
|
| Adolescent | 2 | 1996 | 9495 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 332 | 0.010 |
Why?
|
| Computers | 2 | 1982 | 111 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 332 | 0.010 |
Why?
|
| Chickens | 1 | 1991 | 212 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1991 | 294 | 0.010 |
Why?
|
| Calpain | 1 | 1991 | 113 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1994 | 702 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1996 | 1398 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 2353 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 2685 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1996 | 3514 | 0.000 |
Why?
|